CancerTYPE ID in the Clinic

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.
January 10, 2019

Choosing Immunotherapy

Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.

September 2, 2015

Changing the Way Takeda Oncology Develops Cancer Medicines

Dixie-Lee Esseltine, MD and George Mulligan, PhD offer insight on the impact of ixazomib on Takeda Oncology’s approach to multiple myeloma care and its approach to other cancer types.